The HCPLive migraine page is a comprehensive resource for clinical news and insights on migraine headaches. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for migraines, and more.
October 23rd 2024
A new study found that individuals with healthier cardiovascular systems are more likely to develop migraines, linking incident migraine to lower cardiovascular risk.
Obesity and Chronic Pain Linked
July 23rd 2010Researchers from the University of California San Diego, University of Washington and Veterans' Affairs San Diego Healthcare System evaluated the influence of family history and psychological factors on the relationship between obesity and chronic pain. The team used data from large community-based samples of twins.
Oral Calcitonin Product Advances
July 23rd 2010The ORACAL trial of Tarsa Therapeutics, Inc.'s oral calcitonin product has completed patient enrollment in a multinational, randomized, double-blind, placebo-controlled Phase III trial. The product is for the treatment of postmenopausal osteoporosis. Additionally, the trial completed two separate safety reviews of patient data by an independent data monitoring committee and is set to proceed as planned.
Arthritic Knee Patients May Benefit from Procedure that Incorporates Stem Cells
July 22nd 2010Findings from one of the longest and largest studies on biologic knee joint repair were release by The Stone Research Foundation and published in the July issue of The British Journal of Bone & Joint Surgery.
Study Reveals Cheaper Method of Uncovering Potential ACL Injuries
July 19th 2010Physicians may have a new low-cost, in-office, tool to help identify athletes at increased risk for ACL injuries, according to study results presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting.
Nanobead Technology Can Speed Up Drug Discovery
July 16th 2010The future of drug testing may come to include the use of nanoscopic beads that can match a drug to a disease marker and uncover viable treatments, if the results of a study published in the Journal of Molecular Recognition are taken into consideration.
FDA's Long-acting Opioid REMS Proposal to Focus on CME
July 12th 2010On July 22-23 The FDA will convene a joint meeting of the Anesthetic & Life Support Drugs Advisory Committee and the Drug Safety & Risk Management Advisory committee to discuss its proposal for class-wide Risk Evaluation Mitigation Strategies for long-acting opioids, according to a memo released earlier this month.